Login
$ACXP
$1.09 -$0.05 (4.41%) Close

Ownership

13F as of Q2 2026 · 5.3M shares outstanding

Who owns ACXP?

By type of holder
Institutions 0.0% Insiders 0.2% Everyone else 99.8%
Concentration Top 6 holders own 0.1%
Luci David P 0.1% · Deluccia Robert J 0.1%
Institutional ownership
0.0%
0.0 pts vs last qtr
Institutional holders
0
0 vs last qtr
Net shares bought
0
by institutions in Q2 2026
New / sold out
0 / 0
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Acurx Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025
+85.5%
+85.46% a year
Each share's claim on the business
−46.1%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $3.85M
over 2 fiscal years
Diluted shares, split-adjusted
783.9K1.1M1.5M2024: 808.2K shares'242025: 1.5M shares'25
Buybacks Stock-based comp
$0$1.3M$2.6M2024 buybacks: $02024 stock comp: $2.6M'242025 buybacks: $02025 stock comp: $1.2M'25

How patient are the owners?

No 13F manager reports holding ACXP.

Super Investors

Investment managers reporting ACXP on Form 13F
No 13F manager reports holding ACXP yet.

Institutional Funds

Mutual funds and ETFs reporting ACXP on Form N-PORT; together they hold 0.2% of the company
FE
Fidelity Concord Street Trust
Position value
$11.1K
% of company
0.21%
% of the fund
0.00%
As of
August 31, 2025
FS
Fidelity Concord Street Trust
Position value
$774
% of company
0.01%
% of the fund
0.00%
As of
May 31, 2025

1 more funds behind a free account

See every fund holding Acurx Pharmaceuticals Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
LD
Luci David P
Insider
Shares
3.8K
% of company
0.07%
Change vs last qtr
—
Held since
—
DR
Deluccia Robert J
Insider
Shares
3.4K
% of company
0.06%
Change vs last qtr
—
Held since
—

4 more holders behind a free account

See every insider and 5%+ holder of Acurx Pharmaceuticals Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support